Regulation of adaptive immune cells by inhibitory receptors, such as programmed cell death protein 1 (PD‐1) and cytotoxic T‐lymphocyte associated protein 4 (CTLA4) on T cells, is well studied and successfully therapeutically exploited in cancer and autoimmunity [1, 2]. The gene discussed is PDCD1; the disease is cancer.